According to sources cited by CNBC Awaaz, Natco Pharma is planning to acquire a majority stake in Adcock Holdings, a South Africa-based pharmaceutical company. The Hyderabad-headquartered drug maker is reportedly in talks to take control of Adcock, which is known for its portfolio of generic and over-the-counter (OTC) medicines across Africa.
Adcock Ingram, the parent entity, has a significant presence in the African pharmaceutical market, offering a range of generic and OTC products catering to local healthcare needs.
This potential acquisition could mark a strategic expansion for Natco into the African healthcare market.
The deal, if it materializes, would strengthen Natco’s international footprint and diversify its revenue streams into emerging markets.
Disclaimer: The information provided here is based on reports from CNBC Awaaz and other publicly available sources. It is for informational purposes only and should not be considered as investment advice or a recommendation to buy or sell any securities. Please consult a qualified financial advisor before making any investment decisions.
